In this episode, Ryan Maddox, PhD, discusses his team's study on the incidence of prion disease in the United States from 2003 to 2015, and also examines the topic in the context of his prior research in...
David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.
With the current spike in US cases of acute flaccid myelitis in mind, Matthew J. Elrick, MD, PhD, from the Johns Hopkins School of Medicine, reviews clinical manifestations, diagnosis, and treatment for the...
Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying...
